Dissecting FOXA1 pioneering function by acute pharmacological degradation
Hargis, L. M.; Barta, P. A.; Zhang, Y.; Hayward, R. E.; Cravatt, B. F.; Erb, M. A.
Show abstract
Pioneer factors control transcription by opening chromatin, but a lack of chemical tools has made it difficult to study pioneer activity with kinetic precision. We recently reported covalent chemical probes that remodel the genomic localization of FOXA1, a prototypical pioneer factor essential for the growth of many breast and prostate cancers. Here, we expand the chemical toolbox for FOXA1 by developing a dTAG-based system for small molecule-induced FOXA1 degradation. Coupling pharmacological perturbations to rapid measurements of chromatin structure and function, we find that FOXA1 exclusively initiates chromatin opening at its genomic binding sites. Interestingly, this unidirectional outcome on accessibility both activates and represses gene transcription depending on the chromatin environment surrounding the FOXA1-binding sites. These effects apply to both androgen receptor (AR) target genes and other cancer-relevant genes. Our findings thus uncover regulatory features that translate FOXA1 pioneering activity into both activation and repression of transcriptional programs critical for cancer growth.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Epigenetic control of Topoisomerase 1 activity presents a cancer vulnerability 97%
- MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets 97%
- A recurrent pathogenic BRCA2 truncating variant reveals a role for BRCA2-PCAF complex in modulating NF-κB-driven transcription 96%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- ALC1 links chromatin accessibility to PARP inhibitor response in homologous recombination deficient cells 96%
- Lineage-determining transcription factors constrain cohesin to drive multi-enhancer oncogene regulation 96%
- Polycomb sustains promoters in a deep OFF-state by limiting PIC formation to counteract transcription 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.